An optimization power calculation approach for precision medicine clinical trials

HIGHLIGHTS

  • who: Multineuropathy et al. from the Department of Emergency and Urgent Medicine and Stroke Unit, Santa Maria delle Grazie Hospital, Italy have published the article: An Optimization Power Calculation Approach for Precision Medicine Clinical Trials, in the Journal: (JOURNAL)

SUMMARY

    Neurofibromatosis comprises a group of genetically distinct disorders of the nervous system, unified by the predisposition to develop tumors of the nerve sheaths. The three major forms of neurofibromatosis are: neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2) and schwannomatosis (NF3). Patients with schwannomatosis account for 2-5% of those undergoing resection of schwannomas. MRI . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?